Gilbert's syndrome associated variability: Combination of UDP glucuronosyltransferase (UGT) 1A1 and UGT1A7 gene polymorphisms increase the risk of irinotecan toxicity

被引：0
|
作者：
Lankisch, Tim O.
Schulz, Christoph
Zwingers, Thomas
Erichsen, Thomas J.
Manns, Michael P.
Heinemann, Volker
Strassburg, Christian P.
机构：
[1] Hannover Med Sch, D-3000 Hannover, Germany
[2] Estimate GmbH, Augsburg, Germany
[3] Univ Munich, Med Klin 3, Munich, Germany
来源：
HEPATOLOGY | 2007年 / 46卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1292
引用
收藏
页码：810A / 810A
页数：1
相关论文
共 50 条
  • [41] Genetic linkage of UGT1A7 and UGT1A9 polymorphisms to UGT1A1*6 is associated with low glucuronidase activity for irinotecan metabolite SN-38 in Japanese cancer patients
    Fujita, Ken-Ichi
    Ando, Yuichi
    Nagashima, Fumio
    Yamamoto, Wataru
    Endo, Hisashi
    Araki, Kazuhiro
    Kodama, Keiji
    Miya, Toshimichi
    Narabayashi, Masaru
    Sasaki, Yasutsuna
    CANCER RESEARCH, 2006, 66 (08)
  • [42] Polymorphisms of UGT1A7 and XRCC1 are Associated with an Increased Risk of Hepatocellular Carcinoma in Northeast China
    Zhi-fang Jia1
    2Department of Intervention
    ChineseJournalofCancerResearch, 2010, 22 (04) : 260 - 266
  • [43] Accurate identification of UDP-glucuronosyltransferase 1A1 (UGT1A1) inhibitors using UGT1A1-overexpressing HeLa cells
    Sun, Hua
    Zhou, Xiaotong
    Wu, Baojian
    XENOBIOTICA, 2015, 45 (11) : 945 - 953
  • [44] Structural heterogeneity at the UDP-glucuronosyltransferase 1 locus:: functional consequences of three novel missense mutations in the human UGT1A7 gene
    Guillemette, C
    Ritter, JK
    Auyeung, DJ
    Kessler, FK
    Housman, DE
    PHARMACOGENETICS, 2000, 10 (07): : 629 - 644
  • [45] Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 (UGT1A1) and risk of breast cancer
    Adegoke, OJ
    Shu, XO
    Gao, YT
    Cai, QY
    Breyer, J
    Smith, J
    Zheng, W
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 85 (03) : 239 - 245
  • [46] Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 (UGT1A1) and risk of breast cancer
    Olufemi J. Adegoke
    Xiao Ou Shu
    Yu-Tang Gao
    Qiuyin Cai
    Joan Breyer
    Jeffrey Smith
    Wei Zheng
    Breast Cancer Research and Treatment, 2004, 85 : 239 - 245
  • [47] UGT1A1*6, UGT1A7*3 and UGT1A9*1b polymorphisms are predictive markers for severe toxicity in patients with metastatic gastrointestinal cancer treated with irinotecan-based regimens
    Cui, Chengxu
    Shu, Chang
    Cao, Dandan
    Yang, Yi
    Liu, Junbao
    Shi, Shuping
    Shao, Zhujun
    Wang, Nan
    Yang, Ting
    Liang, Hao
    Zou, Shanshan
    Hu, Songnian
    ONCOLOGY LETTERS, 2016, 12 (05) : 4231 - 4237
  • [48] Polymorphisms of UGT1A7 and XRCC1 are associated with an increased risk of hepatocellular carcinoma in Northeast China
    Jia, Zhi-fang
    Su, Hong-ying
    Li, Xue-lian
    Xu, Xin
    Yin, Zhi-hua
    Guan, Peng
    Zhou, Bao-sen
    CHINESE JOURNAL OF CANCER RESEARCH, 2010, 22 (04) : 260 - 266
  • [49] Bilirubin UDP-glucuronosyltransferase 1A1 (UGT1A1) gene promoter polymorphisms and HPRT, glycophorin A, and micronuclei mutant frequencies in human blood
    Grant, DJ
    Hall, IJ
    Eastmond, DA
    Jones, IA
    Bell, DA
    MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, 2004, 560 (01) : 1 - 10
  • [50] Uridine diphosphate glucuronosyltransferase (UGT) 1A1 and irinotecan: Practical pharmacogenomics arrives in cancer therapy
    O'Dwyer, Peter J.
    Catalano, Robert B.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (28) : 4534 - 4538
12345